 2  9 
0 0
Here we report the structure of the bifunctional CoaBC of M. smegmatis at 2.5 Å. We As the HFCD protein family of flavin-binding proteins are known to form homo-1 1 0 oligomers 13 , we performed native electrospray-ionization mass spectrometry (ESI-MS) 1 1 1 to investigate the stoichiometry of CoaBC, previously proposed to form a dodecamer 13 . other oligomeric species observed in the spectra, which is consistent with a strong 1 1 5 interaction between the subunits of the complex. The dodecamer of MtbCoaBC was 1 1 6 centred around the 56+ charge state, with an observed mass of 537 kDa, while the 1 1 7 dodecamer of MsmCoaBC was centred around the 52+ charge state, with an observed 1 1 8 mass of 523 kDa. These masses are 1-2% higher than the expected masses of 525 and Structures of a few proteins of the HFCD family have been determined [14] [15] [16] [17] [18] . All of these containing Rossmann-fold with trimers forming at each of the vertices of the there are stark differences in the relative position of the residues at this site between the 3 0 8 two enzymes ( Figure S9B ). While we were not able to obtain co-crystal structures with other inhibitors, in silico 3 1 0 docking helped to provide a possible explanation for the structure-activity relationship 3 1 1 observed for series one and two. The highest-scoring docking pose of compound 1b, the 3 1 2 most potent inhibitor of series one, was almost identical to that observed in the co- allosteric site, similar to those formed by compound 1b, but also to interact directly with also predicted to form direct hydrogen bond interactions at the top of the allosteric site, have fewer hydroxyl groups and/or hydroxyl groups in different positions, lose the 3 2 7 ability to form hydrogen bonds, consistent with the weaker inhibitory effect observed 3 2 8 (Table S2 ). The in vitro whole cell activity of the compounds was further evaluated by their ability exhibited activity in media containing glycerol or cholesterol as the main carbon source 3 3 5 (Table 3) . We then tested whether the lack of inhibitory activity could be attributed to 3 3 6 the presence of BSA by determining the whole cell activity of the three most potent displaying the best activity of the three (Table 3 ). The observed differences in potency 3 4 0 between the enzymatic assay and whole cell activity are likely related to low compound 3 4 1 permeation, high efflux or metabolism. CoA is an essential co-factor ubiquitous across all domains of live. For many years, this makes this enzyme a highly attractive drug discovery target.
While a structure of an individual mycobacterial CoaB was available, we were aware 3 5 1 that the many questions remaining at the start of this work about the organization and 3 5 2 regulation of this bi-functional enzyme could have significant implications for drug 3 5 3 discovery. We therefore set out to obtain a full-length structure of a mycobacterial 3 5 4
CoaBC and we successfully solved the MsmCoaBC structure, which shares very high 3 5 5 sequence identity with the M. tuberculosis orthologue (86% full-length, 84% CoaB 3 5 6 enzyme) and hence is a valuable tool for studying M. tuberculosis CoaBC. The 3 5 7 organization of CoaBC is similar to other HFCD family proteins 15 but unique in the 3 5 8 sense that it contains more than one domain and highlights how the arrangement of the 3 5 9 fused enzymes is essential for mycobacterial CoaB dimerisation and function. This due to the extra dimerisation region ( Figure S5 ), but is also known in yeast that the an arrangement for the entire CoA pathway is also present in bacteria.
6 8
Regulation of the CoA biosynthesis pathway was known to occur for other enzymes of the pathway through feedback inhibition by CoA, but no information was available for 3 7 0
CoaBC. We demonstrate that both CoA, as well as several CoA thioesters regulate CoaBC by inhibiting CoaB activity, and that these molecules act competitively for CTP and PPA and non-competitively for L-cysteine. This is consistent with these molecules inhibit both CoaA and CoaD enzymes to varying extents 28, 30, 37 . However, the inhibitory 3 7 5 effect of CoA and its thioesters in the activity of these enzymes is lower when compared to what we observed in CoaBC and consequently the impact of the intracellular level of 3 7 7 these molecules will be predominant in CoaBC. We therefore report a new and 3 7 8 important mechanism of regulation of "de novo" CoA biosynthesis, mediated by the 3 7 9 action of CoA thioesters on CoaBC. Since the reported intracellular levels of these 3 8 0 molecules 31 are normally above the observed IC 50, the activity of CoaBC is highly Although the CoA pathway and CoaBC have been the subject of many drug discovery formation and that compound 1b shows uncompetitive inhibition relative to all CoaB by a natural ligand, as we were unable to identify such a biomolecule. Nevertheless, the conservation of residues at this site, across a variety of bacteria, indicates that this 3 9 9 feature might be common to many, if not all, bacterial CoaBs. NaCl. Fraction purity was determined by SDS-page and the purest fractions were 4 3 2 pooled, concentrated to ~10 mg.mL -1 for MtbCoaBC and 30 mg.mL -1 for MsmCoaBC, (Avestin) and cell lysate was centrifuged at 27000 g for 30 mins to remove cell debris. backing pressure 5 mbar, trap pressure 3-4 × 10 -2 mbar, IMS (N 2 ) pressure 5-6 × 10 -1 4 5 7 mbar and TOF pressure 7-8 × 10 -7 mbar. Spectra were calibrated externally using CTP and 10 mM MgCl 2 , was mixed in 1:1 and 1:2 (protein to reservoir) ratio with well 4 6 6 solution using a mosquito robot (TTP labtech). Initial conditions were obtained in the 4 6 7
Classics lite crystallization screen (Qiagen), solution 1. Crystals obtained in this 4 6 8 condition diffracted poorly, therefore several rounds of optimization were performed. The final optimised condition consisted of 0.1 M BisTris pH 6.5, 10 mM CoCl 2 0.8 M with the exception of the enzymes to all wells, and the reactions started by adding 25 µL 5 1 9
of a 2-times concentrated enzyme mixture. The reaction was carried out for 2 h at room 5 2 0 temperature, before 50 µL of BIOMOL® Green reagent was added and incubated for a further 20 min prior to reading. The commercially available EnzChek pyrophosphate assay kit (E-6645) (Life 5 2 5
Technologies) was used for this assay. The final reaction composition used was 0.03 5 2 6 U/mL inorganic pyrophosphatase, 1 U/mL purine nucleoside phosphorylase, 1 mM control (lacking PPA) and a positive control (lacking inhibitor).
3 9
Competition assays were performed using the same conditions but with variable ferric ammonium citrate adjusted to pH 6.6). waters are represented as red spheres and calcium as a green sphere. Calcium i  s  a  f  l  a  v  i  n  p  r  e  n  y  l  t  r  a  n  s  f  e  r  a  s  e  r  eu  i  r  e  d  f  o  r  b  a  c  t  e  r  i  a  l  u  b  iu  i  n  o  n  e  6  7  1  b  i  o  s  y  n  t  h  e  s  i  s  .   N  a  t  u  r  e   5  2  2  ,  5  0  2  -6  (  2  0  1  5  )  .  6  7  2  1  5  .  B  l  a  e  s  s  e  ,  M  .  ,  K  u  p  k  e  ,  T  .  ,  H  u  b  e  r  ,  R  .  &  S  t  e  i  n  b  a  c  h  e  r  ,  S  .  C  r  y  s  t  a  l  s  t  r  u  c  t  u  r  e  o  f  t  h  e  p  e  p  t  i  d  y  l  -6  7  3  c  y  s  t  e  i  n  e  d  e  c  a  r  b  o  x  y  l  a  s  e  E  p  i  D  c  o  m  p  l  e  x  e  d  w  i  t  h  a  p  e  n  t  a  p  e  p  t  i  d  e  s  u  b  s  t  r  a  t with accession numbers: 6TGV, 6TH2 and 6THC. Figure 6 
